NTP Summary Report on the Metabolism, Disposition, and Toxicity of 1,4-Butanediol (CAS No. 110-63-4)

NTP Technical Report on the Toxicity Studies Series

Volumn TOX-54, Issue , 1996, Pages 1-44

  Irwin, Richard D ^a   Bucher, J R ^b   Burka, L T ^b   Elwell, M R ^b   Mahler, J ^b   Travlos, G S ^b   Jeffcoat, A R ^b   Mathews, J M ^b   Feldman, D B ^b   Troxler, P ^b   Lambright, D D ^b   Bailey, C M ^b   Gunnels, S R ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BUTANEDIOL; 1,4-BUTANEDIOL; BUTANEDIOL;

ANIMAL; BIOTRANSFORMATION; BODY WEIGHT; CARCINOGEN TESTING; DRUG EFFECT; FISCHER 344 RAT; HUMAN; METABOLISM; RAT; REVIEW; SURVIVAL; TISSUE DISTRIBUTION;

ANIMALS; BIOTRANSFORMATION; BODY WEIGHT; BUTYLENE GLYCOLS; CARCINOGENICITY TESTS; HUMANS; RATS; RATS, INBRED F344; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION;

EID: 0030132364     PISSN: 23788984     EISSN: 23788992     Source Type: Book Series    
DOI: None     Document Type: Review

References (80)

1. ADORNATO, B.T., AND TSE, V. (1992). Another health food hazard - -hydroxybutyrate-induced seizures. West. J. Med. 157, 471.
2. ARENA, C., AND FUNG, H.-L. (1980). Absorption of sodium -hydroxybutyrate and its prodrug -butyrolactone: Relationship between in vitro transport and in vivo absorption. J. Pharm. Sci. 69, 356-358.
3. BARKER, S.A, SNEAD, O.C., POLDRUGO, F., LIU, C.-C., FISH, F.P., AND SETTINE, R.L. (1985). Identification and quantitation of 1, 4-butanediol in mammalian tissues: An alternative biosynthetic pathway for gamma-hydroxybutyric acid. Biochem. Pharmacol. 34, 1849-1852.
4. BERGLESON, L.D., VAVER, V.A., PROKAZOVA, N.V., USHAKOV, A.N., AND POPKOVA, G.A. (1966). Diol lipids. Biochim. Biophys. Acta 116, 511-520.
5. BESSMAN, S.P., AND MCCABE, E.R.B., III (1972). 1, 4-Butanediol - A substrate for rat liver and horse liver alcohol dehydrogenases. Biochem. Pharmacol. 21, 1135-1142.
6. CASH, C.D. (1994). Gammahydroxybutyrate: An overview of the pros and cons for it being a neurotransmitter and/or useful therapeutic agent. Neurosci. Behav. Rev. 18, 291-304.
7. CHEMICAL ECONOMICS HANDBOOK (1993). Section 621.5030. Stanford Research Institute, Menlo Park, CA, December 1993 online update.
8. DYER, J.E. (1991). -Hydroxybutyrate: A health-food product producing coma and seizurelike activity. Am. J. Emerg. Med. 9, 321-324.
9. ERWIN, V.G., AND DEITRICH, R.A. (1972). Heterogeneity of alcohol dehydrogenase enzymes in various tissues. Biochem. Pharmacol. 21, 2915-2924.
10. FADDA, F., COLOMBO, G., MOSCA, E., AND GESSA, G.L. (1989). Supression by gamma-hydroxybutyric acid of enthanol withdrawal syndrome in rats. Alcohol Alcohol. 24, 447-451.
11. FERRARA, S.D, ZOTTI, S., TEDESCHI, L., FRISON, G., CASTAGNA, F., GALLIMBERTI, L., GESSA, G.L., AND PALATINI, P. (1992). Pharmacokinetics of -hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br. J. Clin. Pharmacol. 34, 231-235.
12. FISHBEIN, W.N., AND BESSMAN, S.P. (1966). Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of -lactones. I. Tissue localization, stoichiometry, specificity, distinction from esterases. J. Biol. Chem. 241, 4835-4841.
13. GAF Corporation. Summary of Toxicity Information for 1, 4-Butanediol. Pamphlet No. 201-628-3000.
14. GIARMAN, N.J., AND ROTH, R.H. (1964). Differential estimation of gamma-butyrolactone and gammahydroxybutyric acid in rat blood and brain. Science 145, 583-584.
15. GIBSON, K.M., SWEETMAN, L., NYHAN, W.L., JAKOBS, C., RATING, D., SIEMES, H., AND HANEFELD, F. (1983). Succinic semialdehyde dehydrogenase deficiency: An inborn error of gamma-aminobutyric acid metabolism. Clin. Chim. Acta 133, 33-42.
16. GODSCHALK, M., DZOLJIC, M.R., AND BONTA, I.L. (1977). Slow wave sleep and a state resembling absence epilepsy induced in the rat by -hydroxybutyrate. Eur. J. Pharmacol. 44, 105-111.
17. HAZARDOUS SUBSTANCES DATA BASE (HSDB) (1994). Maintained, reviewed, and updated on the National Library of Medicine's Toxicology Data Network (TOXNET). Available through the MEDLARS System.
18. HECHLER, V., GOBAILLE, S., AND MAITRE, M. (1992). Selective distribution pattern of -hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res. 572, 345-348.
19. HUNTER, A.S., LONG, W.J., AND RYRIE, C.G. (1971). An evaluation of gamma-hydroxybutyric acid in paediatric practice. Brit. J. Anaesth. 43, 620-628.
20. JAKOBS, C., BOJASCH, M., MÖNCH, E., RATING, D., SIEMES, H., AND HANEFELD, F. (1981). Urinary excretion of gamma-hydroxybutyric acid in a patient with neurological abnormalities. The probability of a new inborn error of metabolism. Clin. Chim. Acta 111, 169-178.
21. JEDRYCHOWSKI, R., STETKIEWICZ, J., AND STETKIEWICZ, I. (1990a). I. Acute toxicity of 1, 4-butanediol in laboratory animals. Pol. J. Occup. Med. 3, 415-420.
22. JEDRYCHOWSKI, R., GORNY, R., STETKIEWICZ, J., AND STETKIEWICZ, I. (1990b). I. Subacute oral toxicity of 1, 4-butanediol in rats. Pol. J. Occup. Med. 3, 421-427.
23. KAUFMAN, E.E., AND NELSON, T. (1981). Kinetics of coupled -hydroxybutyrate oxidation and + D-glucuronate reduction by an NADP -dependent oxidoreductase. J. Biol. Chem. 256, 6890-6894.
24. + KAUFMAN, E.E., AND NELSON, T. (1987). Evidence for the participation of a cytosolic NADP -dependentoxidoreductase in the catabolism of -hydroxybutyrate in vivo. J. Neurochem. 48, 1935-1941.
25. KAUFMAN, E.E., AND NELSON, T. (1991). An overview of -hydroxybutyrate catabolism: The role of the + cytosolic NADPH -dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid oxoacid transhydrogenase in the initial, rate-limiting step in this pathway. Neurochem. Res. 16, 965-974.
26. KINNEY, L.A., BURGESS, B.A., STULA, E.F., AND KENNEDY, G.L. (1985). Acute and subchronic inhalation toxicity of 1, 4-butanediol in rats. Toxicologist 5, 130 (Abstr. 520).
27. KIRK-OTHMER ENCYCLOPEDIA OF CHEMICAL TECHNOLOGY (1978). 3rd ed., Vol. 1, pp. 245-264. John Wiley and Sons, New York.
28. LETTIERI, J.T., AND FUNG, H.-L. (1976). Absorption and first-pass metabolism of 14C-gammahydroxybutyric acid. Res. Commun. Chem. Pathol. Pharmacol. 13, 425-437.
29. LETTIERI, J.T., AND FUNG, H.-L. (1978). Improved pharmacological activity via pro-drug modification: Comparative pharmacokinetics of sodium -hydroxybutyrate and -butyrolactone. Res. Commun. Chem. Pathol. Pharmacol. 22, 107-118.
30. LETTIERI, J.T., AND FUNG, H.-L. (1979). Dose-dependent pharmacokinetics and hypnotic effects of sodium -hydroxybutyrate in the rat. J. Pharmacol. Exp. Ther. 208, 7-11.
31. LEWIS, R.J., SR., ED. (1991). Hazardous Chemicals Desk Reference, 2nd ed., pp. 189-190. Van Nostrand Reinhold, New York.
32. MACK, R.B. (1993). Love potion number 8 1/2. Gamma-hydroxybutyrate poisoning. N.C. Med. J. 54, 232-233.
33. MAITRE, M., CASH, C., WEISSMAN-NANOPOULOS, D., AND MANDEL, P. (1983). Depolarization-evoked release of -hydroxybutyrate from rat brain slices. J. Neurochem. 41, 287-290.
34. MAMELAK, M. (1989). Gammahydroxybutyrate: An endogenous regulator of energy metabolism. Neurosci. Behav. Rev. 13, 187-198.
35. MAMELAK, M., SCHARF, M.B., AND WOODS, M. (1986). Treatment of narcolepsy with -hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9, 285-289.
36. MANDEL, P., MAITRE, M., VAYER, P., AND HECHLER, V. (1987). Function of -hydroxybutyrate: A putative neurotransmitter. Biochem. Soc. Trans. 15, 215-217.
37. MATERIAL SAFETY DATA SHEET (MSDS) (1985). 1, 4-Butanediol. #G485. Genium Publishing Corporation, Schenectady, NY.
38. MAXWELL, R., AND ROTH, R.H. (1972). Conversion of 1, 4-butanediol to -hydroxybutyric acid in rat brain and in peripheral tissue. Biochem. Pharmacol. 21, 1521-1533.
39. MENON, M.K., CLARK, W.G., SCHINDLER, A., AND ALCARAZ, A. (1973). Studies on the mechanism of the akinetic effects of gamma-hydroxybutyric acid and 1, 4-butanediol. Arch. Int. Pharmacodyn. Ther. 203, 232-242.
40. NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (NIOSH) (1976). National Occupational Hazard Survey (1972-1974).
41. NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH (NIOSH) (1995). National Occupational Exposure Survey (1981-1983), unpublished provisional data as of June 19, 1995.
42. NATIONAL TOXICOLOGY PROGRAM (NTP) (1992). Toxicology and Carcinogenesis Studies of -Butyrolactone (CAS No. 96-48-0) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series No. 406. NIH Publication No. 92-3137. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
43. OSUIDE, G. (1972). Effects of gamma-hydroxybutyrate on chick behaviour, electrocortical activity, and crossed extensor reflexes. Br. J. Pharmacol. 44, 593-604.
44. POLDRUGO, F., AND SNEAD, O.C., III (1986). 1, 4 Butanediol and ethanol compete for degradation in rat brain and liver in vitro. Alcohol 3, 367-370.
45. PRICE, C.J., MARR, M.C., MYERS, C.B., HEINDEL, J.J., AND SCHWETZ, B.A. (1993). Developmental toxicity evaluation of 1, 4-butanediol (BUTE) in Swiss mice. Teratology 47, 433 (Abstr.).
46. ROTH, R.H. (1970). Formation and regional distribution of -hydroxybutyric acid in mammalian brain. Biochem. Pharmacol. 19, 3013-3019.
47. ROTH, R.H., AND GIARMAN, N.J. (1965). Preliminary report on the metabolism of -butyrolactone and -hydroxybutyric acid. Biochem. Pharmacol. 14, 177-178.
48. ROTH, R.H., AND GIARMAN, N.J. (1966). -Butyrolactone and -hydroxybutyric acid - I. Distribution and metabolism. Biochem. Pharmacol. 15, 1333-1348.
49. ROTH, R.H., AND GIARMAN, N.J. (1968). Evidence that central nervous system depression by 1, 4-butanediol is mediated through a metabolite, gamma-hydroxybutyrate. Biochem. Pharmacol. 17, 735-739.
50. ROTH, R.H., AND GIARMAN, N.J. (1970). Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem. Pharmacol. 19, 1087-1093.
51. ROTH, R.H., DELGADO, J.M.R., AND GIARMAN, N. (1966). -Butyrolactone and -hydroxybutyric acid. II. The pharmacologically active form. Int. J. Neuropharmacol. 5, 421-428.
52. RUMIGNY, J.F., MAITRE, M., CASH, C., AND MANDEL, P. (1981). Regional and subcellular localization in rat brain of the enzymes that can synthesize -hydroxybutyric acid. J. Neurochem. 36, 1433-1438.
53. SCALA, R.A., AND PAYNTER, O.E. (1967). Chronic oral toxicity of 1, 3-butanediol. Toxicol. Appl. Pharmacol. 10, 160-164.
54. SMITH, E.L., HILL, R.L., LEHMAN, I.R., LEFKOWITZ, R.J., HANDLER, P., AND WHITE, A. (1983). Principles of Biochemistry: General Aspects. 7th ed., p. 117. McGraw-Hill, New York.
55. SNEAD, O.C., III (1988). -Hydroxybutyrate model of generalized absence seizures: Further characterization and comparison with other absence models. Epilepsia 29, 361-368.
56. SNEAD, O.C., III (1991). The -hydroxybutyrate model of absence seizures: Correlation of regional brain levels of -hydroxybutyric acid and -butyrolactone with spike wave discharges. Neuropharmacology 30, 161-167.
57. SNEAD, O.C., III (1992). Pharmacological models of generalized absence seizures in rodents. J. Neural. Transm. Suppl. 35, 7-19.
58. SNEAD, O.C., III, LIU, C.-C., AND BEARDEN, L.J. (1982). Studies on the relation of -hydroxybutyric acid (GHB) to -aminobutyric acid (GABA). Evidence that GABA is not the sole source for GHB in rat brain. Biochem. Pharmacol. 31, 3917-3923.
59. SNEAD, O.C., III, FURNER, R., AND LIU, C.C. (1989). In vivo conversion of -aminobutyric acid and 1, 4-butanediol to -hydroxybutyric acid in rat brain. Studies using radioisotopes. Biochem. Pharmacol. 38, 4375-4380.
60. SPRINCE, H., JOSEPHS, J.A., JR., AND WILPIZESKI, C.R. (1966). Neuropharmacological effects of 1, 4-butanediol and related congeners compared with those of gamma-hydroxybutyrate and gamma-butyrolactone. Life Sci. 5, 2041-2052.
61. TABERNER, P.V., AND PEARCE, M.J. (1974). Hypothermic and toxic actions of 2-butyne-1, 4-diol and other related diols in the rat. J. Pharm. Pharmacol. 26, 597-604.
62. CONSUMER PRODUCT SAFETY COMMISSION (USCPSC) (1988). Letter from Dr. M.L. Wind to J. Runge, Dynamac Corp.
63. INTERNATIONAL TRADE COMMISSION (USITC) (1982a). Synthetic Organic Chemicals: United States Production and Sales, 1981. USITC Publication 1292. U.S. Government Printing Office, Washington, DC.
64. INTERNATIONAL TRADE COMMISSION (USITC) (1982b). Imports of Benzenoid Chemicals and Products, 1981. USITC Publication 1272. U.S. Government Printing Office, Washington, DC.
65. INTERNATIONAL TRADE COMMISSION (USITC) (1983a). Synthetic Organic Chemicals: United States Production and Sales, 1982. USITC Publication 1422. U.S. Government Printing Office, Washington, DC.
66. INTERNATIONAL TRADE COMMISSION (USITC) (1983b). Imports of Benzenoid Chemicals and Products, 1982. USITC Publication 1401. U.S. Government Printing Office, Washington, DC.
67. INTERNATIONAL TRADE COMMISSION (USITC) (1984a). Synthetic Organic Chemicals: United States Production and Sales, 1983. USITC Publication 1588. U.S. Government Printing Office, Washington, DC.
68. INTERNATIONAL TRADE COMMISSION (USITC) (1984b). Imports of Benzenoid Chemicals and Products, 1983. USITC Publication 1548. U.S. Government Printing Office, Washington, DC.
69. INTERNATIONAL TRADE COMMISSION (USITC) (1985). Synthetic Organic Chemicals: United States Production and Sales, 1984. USITC Publication 1745. U.S. Government Printing Office, Washington, DC.
70. INTERNATIONAL TRADE COMMISSION (USITC) (1986). Synthetic Organic Chemicals: United States Production and Sales, 1985. USITC Publication 1892. U.S. Government Printing Office, Washington, DC.
71. VAN BEMMELEN, F.J., SCHOUTEN, M.J., FEKKES, D., AND BRUINVELS, J. (1985). Succinic semialdehyde as a substrate for the formation of -aminobutyric acid. J. Neurochem. 45, 1471-1474.
72. VAN DER POL, W., VAN DER KLEIJN, E., AND LAUW, M. (1975). Gas chromatographic determination and pharmacokinetics of 4-hydroxybutyrate in dog and mouse. J. Pharmacokinet. Biopharm. 3, 99-113.
73. VAYER, P., MANDEL, P., AND MAITRE, M. (1985). Conversion of -hydroxybutyrate to -aminobutyrate in vitro. J. Neurochem. 45, 810-814.
74. VAYER, P., MANDEL, P., AND MAITRE, M. (1987). Minireview. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41, 1547-1557.
75. VREE, T.B., VAN DALEN, R., VAN DER KLEIJN, AND GIMBRERE, J.S.F. (1978). Pharmacokinetics of 1, 4-butanediol and 4-hydroxybutyric acid in man, rhesus monkey, and dog. Anasthesiol. Intensivmed. 110, 66-73.
76. WALKENSTEIN, S.S., WISER, R., GUDMUNDSEN, C., AND KIMMEL, H. (1964). Metabolism of -hydroxybutyric acid. Biochim. Biophys. Acta 86, 640-642.
77. WEINER, H. (1980). Aldehyde oxidizing enzymes. In Enzymatic Basis of Detoxification (W.P. Jakoby, Ed.), Vol. 1, pp. 261-280. Academic Press, New York.
78. WINTERS, W.D., AND SPOONER, C.E. (1965). A neurophysiological comparison of gamma-hydroxybutyrate with pentobarbital in cats. Electroencephalogr. Clin. Neurophysiol. 18, 287-296.
79. YAMADA, Y., YAMAMOTO, J., FUJIKI, A., HISHIKAWA, Y., AND KANEKO, Z. (1967). Effect of butyrolactone and gamma-hydroxybutyrate on the EEG and sleep cycle in man. Electroencephalogr. Clin. Neurophysiol. 22, 558-562.
80. ZABIC, J.E., VAN DAM, D.P., AND MAICKEL, R.P. (1974). Pharmacological and toxicological studies on 1, 4-butanediol. Res. Commun. Chem. Pathol. Pharmacol. 8, 83-90.